Skip to main content
All lobbying filings

BLOUNT STRATEGIC INITIATIVES

BLOUNT STRATEGIC INITIATIVES filed a Q1 report for MYRIAD GENETICS, INC. on April 9, 2026, reporting $10,000 in lobbying income.

Lobbying for MYRIAD GENETICS, INC. · Myriad is a genetic testing and precision medicine company.

All filings by BLOUNT STRATEGIC INITIATIVES · Everything MYRIAD GENETICS, INC. has reported

 Filing · LD-2 quarterly report Q1 report
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted Apr 9, 2026
Income
$10,000
What the client paid this registrant for the period.
Client based in
District of Columbia

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1

Issues relating to veterans' depression and the Genesight product.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem